What's new

Human medicines European public assessment report (EPAR): Tivdak, tisotumab vedotin, Date of authorisation: 28/03/2025, Status: Authorised

Human medicines European public assessment report (EPAR): Tivdak, tisotumab vedotin, Date of authorisation: 28/03/2025, Status: Authorised

Apr 7, 2025 - 13:27
 0
Human medicines European public assessment report (EPAR): Tivdak, tisotumab vedotin, Date of authorisation: 28/03/2025, Status: Authorised
Human medicines European public assessment report (EPAR): Tivdak, tisotumab vedotin, Date of authorisation: 28/03/2025, Status: Authorised
Read More

Tags:

Previous Article

Wallbox surpasses milestone of 100,000 EV chargers produced at U.S. facility

Next Article

Luxury Collection to debut in Singapore with The Laurus at Resorts World Sentosa

Related Posts

Human medicines European public assessment report (EPAR): Pluvicto, lutetium (177Lu) vipivotide tetraxetan, Date of authorisation: 09/12/2022, Revision: 8, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 11, 2025  0

Oncology Working Party

Oncology Working Party

Feb 21, 2025  0

EMEA-003043-PIP01-21-M01

EMEA-003043-PIP01-21-M01

Mar 12, 2025  0